{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:52:35Z","timestamp":1761947555313},"reference-count":30,"publisher":"Wiley","issue":"s127","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p>Proteinase 3 (PR3)\u2010anti\u2010neutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase (MPO)\u2010ANCA are suggested to play a pathogenic role as they are closely related to the small\u2010vessel vasculitis syndromes, Wegener's granulomatosis and microscopic polyangiitis. A large body of <jats:italic>in vitro<\/jats:italic> and animal experiments supports this concept. The mechanisms of action involve a direct interaction between ANCA and its antigen. The epitope specificity of ANCA may therefore influence the functional effects of ANCA and\/or may reflect the mechanisms behind different disease manifestations or disease courses.<\/jats:p>","DOI":"10.1111\/j.1600-0463.2009.02503.x","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T07:22:14Z","timestamp":1243840934000},"page":"63-66","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epitope\u2010specific anti\u2010neutrophil cytoplasmic antibodies: Do they matter? Can they be detected?"],"prefix":"10.1111","volume":"117","author":[{"given":"ULRICH","family":"SPECKS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,6]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200201000-00004"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005101048"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2007.11.005"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215918"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-0921"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0267"},{"key":"e_1_2_4_8_2","first-page":"2090","article-title":"Pathophysiology of ANCA\u2010associated vasculitis","volume":"66","author":"Hansch GM","year":"2004","journal-title":"are ANCA really pathogenic? A note of caution"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.08.056"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<226::AID-ANR27>3.0.CO;2-Q"},{"key":"e_1_2_4_11_2","first-page":"2025","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels","volume":"43","author":"Boomsma MM","year":"2000","journal-title":"prospective study"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-9-200711060-00005"},{"key":"e_1_2_4_13_2","first-page":"249","article-title":"Characterization of monoclonal antibodies to proteinase 3 and application in the study of epitopes for classical anti\u2010neutrophil cytoplasm antibodies","volume":"3","author":"Sommarin Y","year":"1995","journal-title":"Exp Nephrol"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb05860.x"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1993.tb08192.x"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.216"},{"key":"e_1_2_4_17_2","first-page":"562","article-title":"Interference of PR3\u2010ANCA with the enzymatic activity of PR3","volume":"129","author":"Van Der Geld YM","year":"2002","journal-title":"differences in patients during active disease or remission of Wegener's granulomatosis"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.4.1409"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.9.4722"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb06644.x"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01420.x"},{"key":"e_1_2_4_22_2","first-page":"187","article-title":"Cloning and functional expression of the murine homologue of proteinase 3","volume":"408","author":"Jenne DE","year":"1997","journal-title":"implications for the design of murine models of vasculitis"},{"key":"e_1_2_4_23_2","first-page":"A959","article-title":"Recombinant human\u2010murine chimaeric proteinase 3 (PR3) molecules as tools for PR3\u2010ANCA epitope mapping","volume":"13","author":"Specks U","year":"1999","journal-title":"FASEB J"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02314.x"},{"key":"e_1_2_4_25_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0458"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb06944.x"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023251001261"},{"key":"e_1_2_4_28_2","first-page":"242","article-title":"Epitope analysis of myeloperoxidase (MPO) specific anti\u2010neutrophil cytoplasmic autoantibodies (ANCA) in MPO\u2010ANCA\u2010associated glomerulonephritis","volume":"53","author":"Fujii A","year":"2000","journal-title":"Clin Nephrol"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000354"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP63437"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2007.tb04017.x"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0463.2009.02503.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0463.2009.02503.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:27:33Z","timestamp":1694626053000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0463.2009.02503.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":30,"journal-issue":{"issue":"s127","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1600-0463.2009.02503.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0463.2009.02503.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"2009-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}